Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All melatonin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchMelatoninMelatonin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep dysregulation

Brusco et al., Melatonin Research, doi:10.32794/mr11250089
Dec 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Melatonin for COVID-19
11th treatment shown to reduce risk in December 2020
 
*, now with p = 0.0000002 from 18 studies.
Lower risk for mortality, ventilation, and recovery.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,500+ studies for 81 treatments. c19early.org
Review of melatonin for COVID-19 along with preliminary data suggesting efficacy of melatonin for COVID-19 pneumonia patients.
Brusco et al., 23 Dec 2020, peer-reviewed, 6 authors.
This PaperMelatoninAll
{ 'indexed': {'date-parts': [[2023, 4, 19]], 'date-time': '2023-04-19T08:19:23Z', 'timestamp': 1681892363197}, 'reference-count': 0, 'publisher': 'ST Bio-life', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2021, 1, 1]], 'date-time': '2021-01-01T00:00:00Z', 'timestamp': 1609459200000}, 'content-version': 'unspecified', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by/4.0'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'abstract': '<jats:p>The association of sleep disruption with a higher vulnerability to&#x0D;\n' 'COVID-19 infection is a subject of major clinical importance. In patients with&#x0D;\n' 'pneumonia associated with COVID-19 admitted to non-intensive care unit (NICU) several&#x0D;\n' 'factors, like the disrupting influence of respiratory distress, medication, greater&#x0D;\n' 'stress due to social isolation, and lack of appropriate exposure to environmental&#x0D;\n' 'light can be instrumental to disrupt sleep/wake cycle. The&#x0D;\n' 'therapeutic potential of melatonin to counteract the consequences of COVID-19&#x0D;\n' 'infection has been advocated. Because of its wide-ranging effects as an&#x0D;\n' 'antioxidant, anti-inflammatory, and immunomodulatory compound, melatonin could&#x0D;\n' 'be unique in impairing the consequences of SARS-CoV-2 infection. Melatonin is&#x0D;\n' 'also an effective chronobiotic agent to reverse the circadian disruption of social&#x0D;\n' 'isolation and to control delirium in severely affected patients. Properly&#x0D;\n' 'administered, melatonin may restore the optimal circadian pattern of the&#x0D;\n' 'sleep-wake cycle and improve clinical condition in pneumonia associated with COVID-19&#x0D;\n' 'patients. The present review article discusses the importance of maintaining&#x0D;\n' 'normal sleep and circadian rhythmicity in NICU patients and provides&#x0D;\n' 'preliminary data suggesting the efficacy of melatonin (9 mg/day) to reduce&#x0D;\n' 'length of stay of pneumonia patients associated with COVID-19 in NICU. </jats:p>', 'DOI': '10.32794/mr11250089', 'type': 'journal-article', 'created': {'date-parts': [[2021, 1, 4]], 'date-time': '2021-01-04T02:01:11Z', 'timestamp': 1609725671000}, 'page': '173-188', 'source': 'Crossref', 'is-referenced-by-count': 5, 'title': 'Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep ' 'dysregulation', 'prefix': '10.32794', 'volume': '4', 'author': [ {'given': 'Luis I.', 'family': 'Brusco', 'sequence': 'first', 'affiliation': []}, {'given': 'Pablo', 'family': 'Cruz', 'sequence': 'first', 'affiliation': []}, {'given': 'Alicia V', 'family': 'Cangas', 'sequence': 'first', 'affiliation': []}, {'given': 'Carmen González', 'family': 'Rojas', 'sequence': 'first', 'affiliation': []}, {'given': 'Daniel E', 'family': 'Vigo', 'sequence': 'first', 'affiliation': []}, {'given': 'Daniel Pedro', 'family': 'Cardinali', 'sequence': 'first', 'affiliation': []}], 'member': '18079', 'published-online': {'date-parts': [[2021, 1, 1]]}, 'container-title': 'Melatonin Research', 'original-title': [], 'deposited': { 'date-parts': [[2021, 1, 4]], 'date-time': '2021-01-04T02:01:34Z', 'timestamp': 1609725694000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.melatonin-research.net/index.php/MR/article/view/125'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 1, 1]]}, 'references-count': 0, 'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2021, 1, 3]]}}, 'URL': 'http://dx.doi.org/10.32794/mr11250089', 'relation': {}, 'ISSN': ['2641-0281'], 'subject': [], 'container-title-short': 'Melatonin Res.', 'published': {'date-parts': [[2021, 1, 1]]}}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit